Related Experiment Video
Updated: Jul 10, 2026
06:40
Cost-Efficient Transcriptomic-Based Drug Screening
Published on: February 23, 2024
Cost-effectiveness analysis: should it be required for drug registration and beyond?
1Arnold Consultancy & Technology LLC, 1 Penn Plaza - 36th floor, New York, NY 10119, United States. rarnold@arnoldllc.com
Drug Discovery Today
|November 13, 2007
Summary
Cost-effectiveness analysis (CEA) evaluates trade-offs between healthcare costs and benefits. It guides decisions on new therapies, like the HPV vaccine, especially within budget constraints.
Area of Science:
- Health Economics
- Public Health Policy
- Pharmacoeconomics
Background:
- Cost-effectiveness analysis (CEA) is crucial for evaluating healthcare interventions with varying costs and benefits.
- It is particularly relevant when comparing new strategies against usual care, considering both increased costs and improved effectiveness, or decreased costs and effectiveness.
Purpose of the Study:
- To highlight the application and importance of cost-effectiveness analysis in healthcare decision-making.
- To demonstrate the role of CEA in guiding recommendations for new health strategies, such as vaccinations.
Main Methods:
- The abstract describes the conceptual application of CEA in scenarios involving trade-offs between cost and benefit.
- It uses the example of HPV vaccine recommendations by a US federal vaccine advisory panel to illustrate CEA's relevance.
Main Results:
- CEA provides a framework for assessing interventions where increased cost may yield greater benefit or vice versa.
- Data on the relative cost-effectiveness of the HPV vaccine influenced its recommendation for 11-year-old girls.
Conclusions:
- Cost-effectiveness analysis is a vital tool for navigating healthcare decisions in resource-limited environments.
- CEA supports critical stages of the drug lifecycle, including development, approval, patient segmentation, and pricing strategies.
Related Concept Videos
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...